MG
TMO icon

Mather Group’s Thermo Fisher Scientific TMO Stock Holding History

Mather Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$517K Sell
1,052
-99
-9% -$53.7K 0.01% 476
2025
Q4 		$667K Buy
1,151
+105
+10% +$59.4K 0.01% 353
2025
Q3 		$507K Sell
1,046
-561
-35% -$261K 0.01% 401
2025
Q2 		$652K Sell
1,607
-705
-30% -$295K 0.01% 335
2025
Q1 		$1.15M Sell
2,312
-113
-5% -$61.2K 0.01% 239
2024
Q4 		$1.26M Sell
2,425
-345
-12% -$190K 0.02% 212
2024
Q3 		$1.71M Sell
2,770
-404
-13% -$239K 0.02% 180
2024
Q2 		$1.84M Buy
3,174
+745
+31% +$427K 0.02% 197
2024
Q1 		$1.29M Sell
2,429
-670
-22% -$376K 0.02% 194
2023
Q4 		$1.64M Buy
3,099
+163
+6% +$78.9K 0.03% 172
2023
Q3 		$1.49M Buy
2,936
+408
+16% +$217K 0.03% 168
2023
Q2 		$1.32M Sell
2,528
-929
-27% -$501K 0.02% 191
2023
Q1 		$1.99M Buy
3,457
+1,059
+44% +$597K 0.04% 149
2022
Q4 		$1.32M Buy
2,398
+482
+25% +$255K 0.03% 172
2022
Q3 		$972K Sell
1,916
-322
-14% -$180K 0.02% 201
2022
Q2 		$1.22M Buy
2,238
+576
+35% +$317K 0.03% 162
2022
Q1 		$981K Buy
1,662
+481
+41% +$276K 0.02% 174
2021
Q4 		$788K Sell
1,181
-516
-30% -$322K 0.02% 171
2021
Q3 		$970K Buy
1,697
+918
+118% +$504K 0.02% 118
2021
Q2 		$393K Buy
779
+23
+3% +$10.9K 0.01% 184
2021
Q1 		$345K Buy
756
+73
+11% +$34.8K 0.01% 190
2020
Q4 		$318K Buy
683
+55
+9% +$25.8K 0.01% 182
2020
Q3 		$277K Buy
+628
New +$259K 0.01% 190

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mather Group's TMO Position: Q1 2026 in Review

Mather Group reduced its Thermo Fisher Scientific (TMO) stake by 8.6% in Q1 2026, selling an estimated $53.7K and leaving 1,052 shares worth $517K. The position accounts for 0.01% of the portfolio, ranked #476.

Mather Group first reported a position in TMO in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.99M in Q1 2023. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Mather Group held 1,052 shares of Thermo Fisher Scientific worth $517K as of Q1 2026.
  • Mather Group sold 99 Thermo Fisher Scientific shares in Q1 2026, an estimated $53.7K.
  • Thermo Fisher Scientific made up 0.01% of Mather Group's portfolio in Q1 2026, its #476 holding.
  • Mather Group first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 23 quarters since.
  • Mather Group's Thermo Fisher Scientific position peaked at $1.99M in Q1 2023.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.